Skip to main content

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

ORGO holding history

Organogenesis Holdings Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ORGO overviewAll 13F holders of ORGOFull Q2 2026 holdings

Shares (Q2 2026)
358,708
Value
$871.7K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ORGO by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026358,708$871.7K<0.1%+151,180+72.8%AddedHolders
Q1 2026207,528$491.8K<0.1%+74,920+56.5%AddedHolders
Q4 2025132,608$686.9K<0.1%−360,708−73.1%ReducedHolders
Q3 2025493,316$2.08M<0.1%−6,055−1.2%ReducedHolders
Q2 2025499,371$1.83M<0.1%+153,713+44.5%AddedHolders
Q1 2025345,658$1.49M<0.1%+288,762+507.5%AddedHolders
Q4 202456,896$182.1K<0.1%−1,943−3.3%ReducedHolders
Q3 202458,839$168.3K<0.1%+11,797+25.1%AddedHolders
Q2 202447,042$131.7K<0.1%−28,908−38.1%ReducedHolders
Q1 202475,950$215.7K<0.1%+1,613+2.2%AddedHolders
Q4 202374,337$304.0K<0.1%+26,290+54.7%AddedHolders
Q3 202348,047$152.8K<0.1%+46,046+2,301.1%AddedHolders
Q2 20232,001$6.64K<0.1%−9,133−82.0%ReducedHolders
Q1 202311,134$23.7K<0.1%+5,137+85.7%AddedHolders
Q4 20225,997$16.1K<0.1%+5,996+599,600.0%AddedHolders
Q3 20221$00.0%00.0%UnchangedHolders
Q2 20221$00.0%00.0%UnchangedHolders
Q1 20221$00.0%−589−99.8%ReducedHolders
Q4 2021590$5.00K<0.1%−179,118−99.7%ReducedHolders
Q3 2021179,708$2.56M<0.1%+39,403+28.1%AddedHolders
Q2 2021140,305$2.33M<0.1%+137,988+5,955.5%AddedHolders
Q1 20212,317$42.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.